A Systematic Intracranial Exposure‐Response Evaluation of Brain‐Penetrant Inhibitors: Informing Dose Selection for Brain Metastases
Yuqian Zhao, Weize Huang · 2026
Read A Systematic Intracranial Exposure‐Response Evaluation of Brain‐Penetrant Inhibitors: Informing Dose Selection for Brain Metastases by Yuqian Zhao, Weize Huang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13674225.txt.
Description
When cancer spreads to the brain, drugs must cross the blood-brain barrier to reach it, and picking the right dose is guesswork. Yuqian Zhao and Weize Huang tackle that gap in a 2026 evaluation of brain-penetrant inhibitors. They focus on fourteen tyrosine kinase inhibitors recommended for brain metastases from lung and breast cancers.
For each drug, the pair simulated levels in blood and spinal fluid using published models. They then compared exposure measures, such as how long fluid levels stayed above the concentration that halves tumor growth, with response rates reported in clinical studies. Higher brain exposure tracked with better responses inside the skull. The analysis gives drug developers and doctors a firmer basis for choosing doses when the target sits behind the barrier.
Catalog record
| CREATOR | Yuqian Zhao, Weize Huang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |